PremiumCompany AnnouncementsViatris Inc. Reports Q1 2025 Earnings and Outlook Viatris, Inc. Earnings Call: Mixed Sentiments and Strategic Advances Viatris files automatic mixed securities shelf PremiumThe FlyEarly notable gainers among liquid option names on April 28th Viatris price target lowered to $8 from $10 at BofA Viatris files Effexor supplemental new drug applications to Japan MHLW PremiumThe FlyConcerns increase around adverse effects of benzodiazepines, WSJ says Viatris price target lowered to $13 from $15 at Jefferies Viatris price target lowered to $10 from $14 at Piper Sandler 
